When a company discovers a promising new active substance it is unlikely that they will choose to develop that molecule in one country or regional marketplace. Today it is a global market place and for most companies the strategic decision is to develop a new molecule with the objective of gaining approval and commercialisation of PPs in the shortest possible time in all major global markets. Preparing and organising for a global joint review of the data is an increasingly attractive proposition. From recent experiences the advantages and disadvantages not only to industry but the regulatory community, farmers and consumers of this process will be discussed.  The impact of new European Regulations and hazard based cut-off criteria are having and will have on global development programs will be discussed and illustrated with some recent real world examples.

Global development and registration of new active substances

248th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.